// App-Quantinova.ai

AB0455 : DYSLIPIDEMIA AND ATHEROGENIC RISK IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Researchers

Presenter

  • H.A. Radillo

Principal Investigators

  • J.A. Batun

  • E. Hernandez

Medical Centers

  • Hospital de Alta Especialidad Dr. Gustavo A. Rovirosa Perez, Villahermosa, Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Myocardial infarction

  • Nephrotic syndrome

  • Lupus nephritis

  • Renal disease

  • Dyslipidemia

  • Nephritis

  • Obesity

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Prednisone

  • Carvedilol

  • Amaya

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved